<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1379</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2000</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>STUDIES ON CYTOMEGALOVIRUS INFECTION AND ANTINUCLEAR ANTIBODY AMONG VITILIGO PATIENTS IN AHWAZ IRAN</title>
	<subject_fa>Dermatology</subject_fa>
	<subject>Dermatology</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Recently, using polymerase chain reaction (PCR) technique, the DNA of
cytomegalovirus was detected from depigmented white patches in patients with
vitiligo. The reactivation of infection and occasional anti-CMV IgM circulating
among patients infected by cytomegalovirus has been reported for years. We have
studied 26 patients with clinical signs and symptoms of vitiligo, some of whom
had a history of disease for years. Of these patients, 7 cases (26.92%) showed
positive for anti-CMV IgM, indicating the presence of cytomegalovirus infection
among vitiligo patients which differed significantly from control subjects
(p&lt;O.OOOI). Of these 7 patients positive for anti-CMV IgM, 6 cases (85.71 %)
were also positive for antinuclear antibody (ANA). On the other hand, from among
the 19 cases negative for anti-CMV IgM, 7 cases (36.84%) were positive for
antinuclear antibody (ANA), so the difference was statistically significant (p&lt;O.05).
The prevalence of anti-CMV IgM was higher among the active vitiligo patients
than those with stable vitiligo (p&lt;0.02).
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Cytomegalovirus (CMV), Vitiligo, Antinuclear antibody (ANA).</keyword>
	<start_page>203</start_page>
	<end_page>205</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-306&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>M</first_name>
	<middle_name></middle_name>
	<last_name>MAKVANDI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004333</code>
	<orcid>20031947532846004333</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Departments of Virology and Dermatology, Ahwaz University of Medical Sciences, Ahwaz, I.R. Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>N</first_name>
	<middle_name></middle_name>
	<last_name>SHAHBA</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004334</code>
	<orcid>20031947532846004334</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>N</first_name>
	<middle_name></middle_name>
	<last_name>RADMANESH</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004335</code>
	<orcid>20031947532846004335</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>EM</first_name>
	<middle_name></middle_name>
	<last_name>ABBASI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004336</code>
	<orcid>20031947532846004336</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
